{
  "id": 3612974,
  "title": "FDA approves new pancreatic cancer drug that could extend patients' lives",
  "url": "https://urgent.news/2026/08/26/fda-approves-new-pancreatic-cancer-drug-that-could-extend-patients",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T23:02:00.000Z",
  "source": {
    "name": "CBS News",
    "slug": "cbs-news",
    "url": "https://www.cbsnews.com/news/fda-approves-pancreatic-cancer-drug-daraxonrasib-could-extend-patients-lives/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Quartz",
        "title": "FDA approves Revolution Medicines' first targeted drug for advanced pancreatic cancer",
        "url": "https://urgent.news/2026/08/26/fda-approves-revolution-medicines-first-targeted-drug-for-advanced",
        "published": "2026-08-26T18:20:38.000Z"
      },
      {
        "outlet": "Semafor",
        "title": "FDA approves breakthrough drug for pancreatic cancer treatment",
        "url": "https://urgent.news/2026/08/26/fda-approves-breakthrough-drug-for-pancreatic-cancer-treatment",
        "published": "2026-08-26T22:32:07.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}